Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Cryolife
(NY:
CRY
)
24.44
USD
-0.11 (-0.45%)
Official Closing Price
Updated: 7:00 PM EST, Mar 5, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Cryolife
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
CryoLife Reports Fourth Quarter and Full Year 2020 Financial Results
February 11, 2021
From
PR Newswire
CryoLife Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2020 Financial Results
January 28, 2021
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that fourth quarter and full year 2020 financial results will be released on...
From
PR Newswire
CryoLife to Host Webcast Discussing PROACT Xa Clinical Trial on December 7, 2020
November 19, 2020
Webcast to Include Presentation by Steering Committee Co-Chair John H. Alexander, MD, MHS Highlighting Clinical Trial Progress
From
PR Newswire
CryoLife Reports Third Quarter 2020 Financial Results
November 04, 2020
From
PR Newswire
CryoLife Announces Release Date and Teleconference Call Details for 2020 Third Quarter Financial Results
October 21, 2020
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2020 third quarter financial results will be released on Wednesday, November...
From
PR Newswire
CryoLife to Present at the 18th Annual Morgan Stanley Global Healthcare Conference
September 08, 2020
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming 18th Annual Morgan Stanley Global...
From
PR Newswire
CryoLife Acquires Ascyrus Medical
September 02, 2020
Conference Call and Webcast Today, September 2, 2020 at 5:00 pm ET
From
PR Newswire
CryoLife to Participate in Upcoming Virtual Investor Conferences
August 06, 2020
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in two upcoming virtual investor conferences.
From
PR Newswire
CryoLife Reports Second Quarter 2020 Financial Results
July 30, 2020
From
PR Newswire
CryoLife Announces Release Date and Teleconference Call Details for 2020 Second Quarter Financial Results
July 21, 2020
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2020 second quarter financial results will be released on Thursday, July 30,...
From
PR Newswire
CryoLife Announces Pricing of $100 Million Convertible Senior Notes Offering
June 19, 2020
CryoLife, Inc. (NYSE: CRY) ("CryoLife" or "the Company"), a leading cardiac and vascular surgery company focused on aortic disease, today announced the pricing of $100 million aggregate principal...
From
PR Newswire
CryoLife Announces Offering of Convertible Senior Notes Due 2025
June 18, 2020
CryoLife, Inc. (NYSE: CRY) ("CryoLife" or "the Company"), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it intends to offer, subject to market...
From
PR Newswire
NYSE: CRY Investor Notice: Investigation over Potential Wrongdoing at CryoLife, Inc.
June 16, 2020
San Diego, CA -- (SBWIRE) -- 06/16/2020 -- An investigation on behalf of investors in CryoLife, Inc. (NYSE: CRY) shares over potential wrongdoing at CryoLife, Inc. was announced.
From
SBWire - Latest Press Releases
CryoLife Initiates Enrollment in PROACT Xa Clinical Trial
May 07, 2020
Study Designed to Evaluate the Use of Apixaban in On-X Aortic Valve Patients
From
PR Newswire
CryoLife Reports First Quarter 2020 Financial Results
April 30, 2020
From
PR Newswire
CryoLife Announces Release Date and Teleconference Call Details for 2020 First Quarter Financial Results
April 16, 2020
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2020 first quarter financial results will be released on Thursday, April 30,...
From
PR Newswire
CryoLife, Inc. (NYSE: CRY) Shareholder Notice: Investigation over Possible Violations of Securities Laws
April 15, 2020
San Diego, CA -- (SBWIRE) -- 04/15/2020 -- An investigation for investors in CryoLife, Inc. (NYSE: CRY) shares over potential securities laws violations by CryoLife, Inc. was announced.
From
SBWire - Latest Press Releases
CryoLife Provides Business Update in Response to COVID-19 Pandemic
April 01, 2020
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today it has taken multiple steps to focus on the health and welfare of its employees,...
From
PR Newswire
CryoLife Receives CE Mark for E-vita Open NEO™ Hybrid Stent Graft
March 04, 2020
Newest Hybrid Stent Graft Offering Enhances Ease-of-Use
From
PR Newswire
CryoLife Receives CE Mark for On-X® Ascending Aortic Prosthesis
February 27, 2020
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today it has received CE Mark for the On-X Ascending Aortic Prosthesis (AAP), allowing...
From
PR Newswire
CryoLife Reports Fourth Quarter and Full Year 2019 Financial Results
February 13, 2020
From
PR Newswire
CryoLife Announces Release Date and Teleconference Call Details for 2019 Fourth Quarter and Year-end Financial Results
January 30, 2020
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2019 fourth quarter and year-end financial results will be released on...
From
PR Newswire
CryoLife Receives FDA Authorization to Commence PROACT Xa Clinical Trial
December 23, 2019
Study Designed to Evaluate the Use of Apixaban in On-X Aortic Valve Patients
From
PR Newswire
CryoLife and Misonix Enter Into Distribution Agreement for NeoPatch
December 19, 2019
CryoLife Will Supply NeoPatch, a Chorioamniotic Membrane Tissue, to Misonix
From
PR Newswire
CryoLife Receives CE Mark for E-nya Thoracic Stent Graft
December 02, 2019
Product Launch Anticipated in the First Quarter 2020
From
PR Newswire
CryoLife Receives CE Mark for E-nside Thoraco-abdominal Stent Graft
December 02, 2019
First Off-the-Shelf Thoraco-abdominal Stent Graft with Pre-Cannulated Inner Branch Technology
From
PR Newswire
CryoLife Reports Third Quarter 2019 Financial Results
October 30, 2019
From
PR Newswire
CryoLife Announces Release Date and Teleconference Call Details for 2019 Third Quarter Financial Results
October 16, 2019
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2019 third quarter financial results will be released on Wednesday, October...
From
PR Newswire
Accelmed Launches Accelmed Ventures II, a New $100 Million Venture HealthTech Fund
October 07, 2019
The new fund has already received a commitment from an anchor investor, Vincent Tchenguiz
From
PR Newswire
CryoLife to Participate in the Deutsche Bank 27th Annual Leveraged Finance Conference
September 18, 2019
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in a fireside chat with analysts and investors at the...
From
PR Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.